Literature DB >> 25994160

Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.

Brunella Posteraro1, Ljupcho Efremov2, Emanuele Leoncini2, Rosarita Amore2, Patrizia Posteraro3, Walter Ricciardi2, Maurizio Sanguinetti4.   

Abstract

Accurate identification of pathogenic species is important for early appropriate patient management, but growing diversity of infectious species/strains makes the identification of clinical yeasts increasingly difficult. Among conventional methods that are commercially available, the API ID32C, AuxaColor, and Vitek 2 systems are currently the most used systems in routine clinical microbiology. We performed a systematic review and meta-analysis to estimate and to compare the accuracy of the three systems, in order to assess whether they are still of value for the species-level identification of medically relevant yeasts. After adopting rigorous selection criteria, we included 26 published studies involving Candida and non-Candida yeasts that were tested with the API ID32C (674 isolates), AuxaColor (1,740 isolates), and Vitek 2 (2,853 isolates) systems. The random-effects pooled identification ratios at the species level were 0.89 (95% confidence interval [CI], 0.80 to 0.95) for the API ID32C system, 0.89 (95% CI, 0.83 to 0.93) for the AuxaColor system, and 0.93 (95% CI, 0.89 to 0.96) for the Vitek 2 system (P for heterogeneity, 0.255). Overall, the accuracy of studies using phenotypic analysis-based comparison methods was comparable to that of studies using molecular analysis-based comparison methods. Subanalysis of studies conducted on Candida yeasts showed that the Vitek 2 system was significantly more accurate (pooled ratio, 0.94 [95% CI, 0.85 to 0.99]) than the API ID32C system (pooled ratio, 0.84 [95% CI, 0.61 to 0.99]) and the AuxaColor system (pooled ratio, 0.76 [95% CI, 0.67 to 0.84]) with respect to uncommon species (P for heterogeneity, <0.05). Subanalysis of studies conducted on non-Candida yeasts (i.e., Cryptococcus, Rhodotorula, Saccharomyces, and Trichosporon) revealed pooled identification accuracies of ≥98% for the Vitek 2, API ID32C (excluding Cryptococcus), and AuxaColor (only Rhodotorula) systems, with significant low or null levels of heterogeneity (P > 0.05). Nonetheless, clinical microbiologists should reconsider the usefulness of these systems, particularly in light of new diagnostic tools such as matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, which allow for considerably shortened turnaround times and/or avoid the requirement for additional tests for species identity confirmation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25994160      PMCID: PMC4508456          DOI: 10.1128/JCM.00802-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  59 in total

Review 1.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.

Authors:  M A Pfaller; M Castanheira; S R Lockhart; A M Ahlquist; S A Messer; R N Jones
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

3.  Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts.

Authors:  Caroline Loïez; Frédéric Wallet; Boualem Sendid; René J Courcol
Journal:  Diagn Microbiol Infect Dis       Date:  2006-08-28       Impact factor: 2.803

4.  Comparative study of seven commercial yeast identification systems.

Authors:  P E Verweij; I M Breuker; A J Rijs; J F Meis
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

Review 5.  Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients.

Authors:  John R Perfect; Ray Hachem; John R Wingard
Journal:  Clin Infect Dis       Date:  2014-11-15       Impact factor: 9.079

6.  Comparison of four commercialized biochemical systems for clinical yeast identification by colour-producing reactions.

Authors:  A Paugam; M Benchetrit; A Fiacre; C Tourte-Schaefer; J Dupouy-Camet
Journal:  Med Mycol       Date:  1999-02       Impact factor: 4.076

7.  Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; E Nagy; S Dobiasova; M Rinaldi; R Barton; A Veselov
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

Review 8.  Yeast identification--past, present, and future methods.

Authors:  D H Pincus; S Orenga; S Chatellier
Journal:  Med Mycol       Date:  2007-03       Impact factor: 4.076

9.  Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom.

Authors:  Andrew M Borman; Adrien Szekely; Chistopher J Linton; Michael D Palmer; Phillipa Brown; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

10.  Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.

Authors:  Florence Chapeland-Leclerc; Christophe Hennequin; Nicolas Papon; Thierry Noël; Aurélie Girard; Gérard Socié; Patricia Ribaud; Claire Lacroix
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

View more
  14 in total

1.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.

Authors:  Zhimin Hu; Juling Zhang; Zhongju Chen; Zhengjiang Jin; Pei Leng; Junying Zhou; Xiaofang Xie
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

2.  Reagent-Free Identification of Clinical Yeasts by Use of Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy.

Authors:  Lisa M T Lam; Philippe J Dufresne; Jean Longtin; Jacqueline Sedman; Ashraf A Ismail
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.

Authors:  Meng Xiao; Xin Fan; Xin-Xin Chen; He Wang; Li Zhang; Zhi-Peng Xu; Timothy Kudinha; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2015-11-11       Impact factor: 5.948

4.  Rapid Evaporative Ionisation Mass Spectrometry (REIMS) Provides Accurate Direct from Culture Species Identification within the Genus Candida.

Authors:  Simon J S Cameron; Frances Bolt; Alvaro Perdones-Montero; Tony Rickards; Kate Hardiman; Alireza Abdolrasouli; Adam Burke; Zsolt Bodai; Tamas Karancsi; Daniel Simon; Richard Schaffer; Monica Rebec; Julia Balog; Zoltan Takáts
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

5.  Oligonucleotide Array and VITEK Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Species Identification of Blood Yeast Isolates.

Authors:  Ming-Chi Li; Tsung C Chang; Hung-Mo Chen; Chi-Jung Wu; Shu-Li Su; Susan S-J Lee; Po-Lin Chen; Nan-Yao Lee; Ching-Chi Lee; Chia-Wen Li; Ling-Shan Syue; Wen-Chien Ko
Journal:  Front Microbiol       Date:  2018-01-26       Impact factor: 5.640

Review 6.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

7.  Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation.

Authors:  Sara Auricchio; Maria Enrica Giovenzana; Marco Pozzi; Andrea Galassi; Gennaro Santorelli; Beatrice Dozio; Renzo Scanziani
Journal:  Clin Kidney J       Date:  2018-07-18

8.  Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Mohammad Kord; Maryam Roudbary; Hossein Zarrinfar; Wenjie Fang; Sayed Jamal Hashemi; Mohammad Javad Najafzadeh; Sadegh Khodavaisy; Weihua Pan; Wanqing Liao; Hamid Badali; Sassan Rezaie; Kamiar Zomorodian; Ferry Hagen; Teun Boekhout
Journal:  Front Cell Infect Microbiol       Date:  2019-02-15       Impact factor: 5.293

Review 9.  Susceptibility Testing of Fungi to Antifungal Drugs.

Authors:  Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Fungi (Basel)       Date:  2018-09-15

10.  Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR.

Authors:  Amir Arastehfar; Wenjie Fang; Weihua Pan; Wanqing Liao; Liang Yan; Teun Boekhout
Journal:  BMC Infect Dis       Date:  2018-09-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.